Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | MITF | O75030 | 1/20 | 0.57 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8731557 | 1.00 | P4HTM (0.68) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL29789035 | 1.00 | P4HTM (0.68) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5293348 | 0.88 | ALDH1A1 (0.62) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5293356 | 0.88 | ALDH1A1 (0.62) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL6853005 | 0.84 | CA12 (0.57) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL11660063 | 0.84 | P4HTM (0.68) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL11660064 | 0.84 | P4HTM (0.68) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL3611594 | 0.84 | KDM4E (0.61) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL3611598 | 0.84 | KDM4E (0.61) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL9836730 | 0.82 | P4HTM (0.66) | P4HTMKDM4EALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119114162-B | Heterogeneous metal photocatalyst and preparation method and application thereof | 中山大学 | 2025-03-14 | — | — | CN | claimed |
| CN-119114162-A | Heterogeneous metal photocatalyst and preparation method and application thereof | 中山大学 | 2024-12-13 | — | — | CN | claimed |
| US-10647733-B2 | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations | THE UNIVERSITY OF CHICAGO (US) | 2020-05-12 | — | — | US | claimed |
| CN-119114162-B | Heterogeneous metal photocatalyst and preparation method and application thereof | 中山大学 | 2025-03-14 | — | — | CN | disclosed |
| CN-119114162-A | Heterogeneous metal photocatalyst and preparation method and application thereof | 中山大学 | 2024-12-13 | — | — | CN | disclosed |
| US-10647733-B2 | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations | THE UNIVERSITY OF CHICAGO (US) | 2020-05-12 | — | — | US | disclosed |
| US-20170182486-A1 | METAL-ORGANIC FRAMEWORKS CONTAINING NITROGEN-DONOR LIGANDS FOR EFFICIENT CATALYTIC ORGANIC TRANSFORMATIONS | THE UNIVERSITY OF CHICAGO (US) | 2017-06-29 | — | — | US | disclosed |
| EP-0799827-B1 | ACRYLAMIDE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | KYORIN SEIYAKU KK (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-5786486-A | ANTIMICROBIAL, ANTITUMOR AGENTS | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| EP-0799827-A1 | ACRYLAMIDE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1997-10-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10647733-B2 | Metal-organic frameworks containing nitrogen-donor ligands for efficient catalytic organic transformations | NCLN, MDH1, NNMT | P4HTM 4822/4885KDM4E 4407/4885ALDH1A1 1706/4885 |
| US-20170182486-A1 | METAL-ORGANIC FRAMEWORKS CONTAINING NITROGEN-DONOR LIGANDS FOR EFFICIENT CATALYTIC ORGANIC TRANSFORMATIONS | NCLN, MDH1, NNMT | P4HTM 4822/4885KDM4E 4407/4885ALDH1A1 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.